Suprachoroidal microneedle drug delivery is an emerging therapeutic strategy in ophthalmology aimed at enhancing the treatment of posterior segment eye diseases. The suprachoroidal space, located between the sclera and choroid, provides a targeted route for delivering medications directly to the retina and choroid, key sites involved in conditions such as age-related macular degeneration, uveitis, and diabetic macular edema. This approach minimizes systemic absorption and reduces exposure to anterior eye structures.
Suprachoroidal injections are minimally invasive, performed in outpatient settings under topical anesthesia, and have demonstrated up to 60-fold higher drug concentrations in target tissues compared to traditional delivery methods. Here is a quick question about suprachoroidal microneedle drug delivery! References : Investigative Ophthalmology & Visual Science,…
